Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy

Non-Small Cell Lung Carcinoma (NSCLC), is the most common type of lung cancer (more than 80% of all cases). Small molecule Tyrosine Kinase (TK) Inhibitors acting on the Epidermal Growth Factor Receptors (EGFRs) are standard therapies for patients with NSCLC harboring EGFR-TK inhibitor-sensitizing mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbuzenko, Olga B., Kuzmov, Andriy, Taratula, Oleh, Pine, Sharon R., Minko, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857061/
https://www.ncbi.nlm.nih.gov/pubmed/31754402
http://dx.doi.org/10.7150/thno.39816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857061/
https://www.ncbi.nlm.nih.gov/pubmed/31754402
http://dx.doi.org/10.7150/thno.39816

Ejemplares similares